These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 24824263)
1. Progress on the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Wang C; Lu H; Yang C; Luo Y Chin Med J (Engl); 2014; 127(10):1960-3. PubMed ID: 24824263 [TBL] [Abstract][Full Text] [Related]
2. HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy. Wen J; Xie K; Zhang M; Chen J; Zhang J; Cheng D; Li X; Ji S; Liu Z Medicine (Baltimore); 2016 Sep; 95(37):e4809. PubMed ID: 27631233 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
4. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
5. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
6. Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor. Jatem Escalante E; Segarra Medrano A; Carnicer Cáceres C; Martín-Gómez MA; Salcedo Allende MT; Ostos Roldan H; Agraz Pamplona I Nefrologia; 2015; 35(5):479-86. PubMed ID: 26306972 [TBL] [Abstract][Full Text] [Related]
7. Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen. Škoberne A; Behnert A; Teng B; Fritzler MJ; Schiffer L; Pajek J; Lindič J; Haller H; Schiffer M Eur J Clin Invest; 2014 Aug; 44(8):753-65. PubMed ID: 24942189 [TBL] [Abstract][Full Text] [Related]
8. [Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?]. Netti GS; Ranieri E G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030016 [TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Hoxha E; Kneißler U; Stege G; Zahner G; Thiele I; Panzer U; Harendza S; Helmchen UM; Stahl RA Kidney Int; 2012 Oct; 82(7):797-804. PubMed ID: 22673885 [TBL] [Abstract][Full Text] [Related]
10. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Kumar V; Ramachandran R; Kumar A; Nada R; Suri D; Gupta A; Kohli HS; Gupta KL; Jha V Nephrology (Carlton); 2015 Aug; 20(8):572-5. PubMed ID: 26194981 [TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the CTLD7 domain of human M-type phospholipase A2 receptor. Yu B; Hu Z; Kong D; Cheng C; He Y J Struct Biol; 2019 Sep; 207(3):295-300. PubMed ID: 31271865 [TBL] [Abstract][Full Text] [Related]
12. Immunology of membranous nephropathy: from animal models to humans. Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770 [TBL] [Abstract][Full Text] [Related]
13. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy. Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659 [TBL] [Abstract][Full Text] [Related]
14. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568 [TBL] [Abstract][Full Text] [Related]
15. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223 [TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of membranous nephropathy: evolution and revolution. Glassock RJ Curr Opin Nephrol Hypertens; 2012 May; 21(3):235-42. PubMed ID: 22388552 [TBL] [Abstract][Full Text] [Related]
17. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy. Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283 [TBL] [Abstract][Full Text] [Related]
18. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176 [TBL] [Abstract][Full Text] [Related]
19. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Xie Q; Li Y; Xue J; Xiong Z; Wang L; Sun Z; Ren Y; Zhu X; Hao CM Am J Nephrol; 2015; 41(4-5):345-53. PubMed ID: 26087695 [TBL] [Abstract][Full Text] [Related]